IE32140B1 - Vaccines - Google Patents
VaccinesInfo
- Publication number
- IE32140B1 IE32140B1 IE713/68A IE71368A IE32140B1 IE 32140 B1 IE32140 B1 IE 32140B1 IE 713/68 A IE713/68 A IE 713/68A IE 71368 A IE71368 A IE 71368A IE 32140 B1 IE32140 B1 IE 32140B1
- Authority
- IE
- Ireland
- Prior art keywords
- informationally
- viruses
- antigen
- vaccines
- influenza
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000007900 aqueous suspension Substances 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 206010022000 influenza Diseases 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000588807 Bordetella Species 0.000 abstract 1
- 241000282465 Canis Species 0.000 abstract 1
- 102000016607 Diphtheria Toxin Human genes 0.000 abstract 1
- 108010053187 Diphtheria Toxin Proteins 0.000 abstract 1
- 208000000655 Distemper Diseases 0.000 abstract 1
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 abstract 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 abstract 1
- 201000005505 Measles Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 206010043376 Tetanus Diseases 0.000 abstract 1
- 108010055044 Tetanus Toxin Proteins 0.000 abstract 1
- 241000700647 Variola virus Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 229940001007 aluminium phosphate Drugs 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 210000004671 cell-free system Anatomy 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 206010014599 encephalitis Diseases 0.000 abstract 1
- 210000000416 exudates and transudate Anatomy 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000002751 lymph Anatomy 0.000 abstract 1
- 210000001165 lymph node Anatomy 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
- 239000003998 snake venom Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEJ0033936 | 1967-06-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE32140L IE32140L (en) | 1968-12-19 |
| IE32140B1 true IE32140B1 (en) | 1973-04-18 |
Family
ID=7204943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE713/68A IE32140B1 (en) | 1967-06-19 | 1968-06-17 | Vaccines |
Country Status (13)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754934A (fr) * | 1969-08-16 | 1971-02-17 | Jachertz Diether | Procede de production enzymatique d'arn-messager |
| GB1594097A (en) | 1976-12-16 | 1981-07-30 | Int Inst Of Differentiation | Production of specific immune nucleic acids cell dialysates and antibodies |
| DE3115559A1 (de) * | 1981-04-16 | 1982-10-28 | Kommanditgesellschaft Schwarzhaupt, 5000 Köln | Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben |
| GB2216416B (en) * | 1988-03-11 | 1992-06-24 | Sandoz Ltd | Nucleobase source for the stimulation of the immune system |
| US6673776B1 (en) | 1989-03-21 | 2004-01-06 | Vical Incorporated | Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
-
1967
- 1967-06-19 DE DE1617545A patent/DE1617545C2/de not_active Expired
-
1968
- 1968-06-12 IL IL30168A patent/IL30168A/en unknown
- 1968-06-15 NO NO2340/68A patent/NO124840B/no unknown
- 1968-06-17 CH CH893668A patent/CH513241A/de not_active IP Right Cessation
- 1968-06-17 IE IE713/68A patent/IE32140B1/xx unknown
- 1968-06-17 NL NL6808486A patent/NL6808486A/xx unknown
- 1968-06-17 AT AT576668A patent/AT282821B/de not_active IP Right Cessation
- 1968-06-18 DK DK286268AA patent/DK119724B/da unknown
- 1968-06-18 ES ES355121A patent/ES355121A1/es not_active Expired
- 1968-06-19 BE BE716806D patent/BE716806A/xx unknown
- 1968-06-19 FR FR1588820D patent/FR1588820A/fr not_active Expired
- 1968-06-19 GB GB1229888D patent/GB1229888A/en not_active Expired
- 1968-06-19 BR BR199970/68A patent/BR6899970D0/pt unknown
- 1968-09-18 FR FR166589A patent/FR7781M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE716806A (enrdf_load_stackoverflow) | 1968-12-19 |
| NL6808486A (enrdf_load_stackoverflow) | 1968-12-20 |
| ES355121A1 (es) | 1969-11-16 |
| DE1617545A1 (de) | 1971-04-01 |
| CH513241A (de) | 1971-09-30 |
| IL30168A (en) | 1973-05-31 |
| NO124840B (enrdf_load_stackoverflow) | 1972-06-12 |
| FR1588820A (enrdf_load_stackoverflow) | 1970-03-16 |
| DK119724B (da) | 1971-02-15 |
| IE32140L (en) | 1968-12-19 |
| AT282821B (de) | 1970-07-10 |
| FR7781M (enrdf_load_stackoverflow) | 1970-03-23 |
| GB1229888A (enrdf_load_stackoverflow) | 1971-04-28 |
| DE1617545C2 (de) | 1983-11-03 |
| BR6899970D0 (pt) | 1973-02-13 |
| IL30168A0 (en) | 1968-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Milich | Synthetic T and B cell recognition sites: implications for vaccine development | |
| Wiktor et al. | Cultivation of rabies virus in human diploid cell strain WI-38 | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| Oxford et al. | The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection | |
| Sundquist et al. | Influenza virus ISCOMs: antibody response in animals | |
| Zygraich et al. | In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus | |
| CA1045546A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| US4117112A (en) | Vaccine for prevention of feline leukemia | |
| Atanasiu et al. | Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3 | |
| IE32140L (en) | Vaccine | |
| US3927208A (en) | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them | |
| Glasgow et al. | Isoprinosine: lack of antiviral activity in experimental model infections | |
| Reiss et al. | Specificity of the helper T cell for the cytolytic T lymphocyte response to influenza viruses | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| Norrby et al. | Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus | |
| Barbour et al. | Comparison of Mycoplasma gallisepticum subunit and whole organism vaccines containing different adjuvants by western immunoblotting | |
| Laver et al. | Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine | |
| US3629413A (en) | Polyvalent bovine vaccines and methods of making and using same | |
| US5006335A (en) | Live vaccine against mumps and process for obtaining thereof | |
| McNeill | The antibody response of rabbits to inactivated vaccinia virus | |
| Millian et al. | Antibody response of man to canine distemper virus | |
| McLaren et al. | Immunity to influenza in ferrets: XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization | |
| Srivastava et al. | Studies on the immunogenicity of Streptococcus equi vaccines in foals | |
| Luzzio | Demonstration of blood group substance A bound to Pasteurella pestis | |
| Norrby | Characteristics of the progeny derived from multiplication of Sendai virus in a measles virus carrier cell line |